Madison, WI USA. (March 19, 2015) Promega Corporation announces the release of the PowerQuant™ System , a probe-based 4-target, 5-dye real-time PCR method. The system allows laboratories to determine human and male DNA concentrations in a sample, assess the integrity of the DNA sample and detect possible PCR inhibitors in approximately one hour.

The PowerQuant System ensures that DNA detected in the quantification step of the workflow equates to a usable STR profile. Accurate and sensitive DNA quantification plays a key role in ensuring successful STR results, and because many samples are precious, getting it right the first time is critical. Inaccurate determination of the amount of DNA present in the sample can lead to unusable STR profiles, and repeating the STR assay with corrected DNA template amounts can waste both reagents and a user's time.

PowerQuant also allows laboratories to assess the quality of the DNA sample, whether it...

Using the PowerQuant System, along with the PowerQuant™ Analysis Tool program, for quality assessment and STR normalization values, laboratories are able to make the best decision about what steps to take next in their workflow and eliminate guesswork about DNA samples.

Developmental validation efforts are under way.

About Promega
Promega Corporation has provided products for DNA-based human identification for over 20 years. Promega is a leader in providing innovative solutions and technical support to the life sciences industry. The company's 3,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors.

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?